✦ LIBER ✦

Bioavailability of hydroxycinnamates: a brief review of in vivo and in vitro studies

✍ Scribed by Zhaohui Zhao; Mohammed H. Moghadasian

Publisher: Springer
Year: 2009
Tongue: English
Weight: 285 KB
Volume: 9
Category: Article
ISSN: 1568-7767
DOI: 10.1007/s11101-009-9145-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In vitro and in vivo studies on the toxi

In vitro and in vivo studies on the toxicity of dental resin components: a review

✍ Michel Goldberg 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 167 KB

In vitro and in vivo studies of mesothel

In vitro and in vivo studies of mesothelioma

✍ Harvey I. Pass; Daphne J. Y. Mew 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 942 KB

Pleural mesothelioma is an asbestos-related malignancy characterized by progressive local growth, late metastases, and median survivals between 8 and 18 months. It is only recently that the in vitro and in vivo characteristics of the malignancy has been investigated. These investigations have been a

Bioavailability of tolazamide from table

Bioavailability of tolazamide from tablets: Comparison of in vitro and in vivo results

✍ P. G. Welling; R. B. Patel; U. R. Patel; W. R. Gillespie; W. A. Craig; K. S. Alb 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 582 KB

Comparison of in vitro dissolution and i

Comparison of in vitro dissolution and in vivo bioavailability of methaqualone tablets in humans

✍ Roger G. Stoll; George C. Chao; Harvey J. Hoyt; Avraham Yacobi 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 253 KB 👁 1 views

Role of hydroxycinnamic acids in food fl

Role of hydroxycinnamic acids in food flavor: a brief overview

✍ Deshou Jiang; Devin G. Peterson 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 307 KB

Comparative in vitro and in vivo bioavai

Comparative in vitro and in vivo bioavailability of naproxen from tablet and caplet formulations

✍ B. G. Charles; G. A. G. Mogg 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 415 KB 👁 2 views

## Abstract A 500 mg dose of naproxen in a caplet formulation (product A) or a tablet (Naprosyn 500, product B) was administered to 14 fasting healthy subjects on two separate occasions, separated by a 1–2 week washout period in an open, randomized crossover. Blood samples were drawn periodically a